Arrhythmia Research Technology (HRT) Reports Q1 EPS of $0.04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Arrhythmia Research Technology, Inc. Reports First Quarter 2015 Results
May 13, 2015 4:05 PM EDTFirst quarter net sales were $5.9 million Generated $275 thousand of cash from operations in the first quarter
FITCHBURG, Mass., May 13, 2015 (GLOBE NEWSWIRE) -- Arrhythmia Research Technology, Inc. (NYSE MKT: HRT) (the "Company"), through its wholly-owned subsidiary, Micron Products, Inc., a diversified contract manufacturing organization that produces highly-engineered, innovative medical device technologies requiring precision machining and injection molding, announced today results for its first quarter ended March 31, 2015.
Salvatore Emma, Jr., President and CEO, commented, "In the quarter, we reported a 25.6% increase in net sales... More
